教育工具改善狼疮妊娠妇女子痫前期知识与阿司匹林依从性:PREPARE试验
该随机对照试验纳入73例妊娠≤17周的SLE孕妇,比较常规护理联合教育工具与单纯常规护理对子痫前期知识及阿司匹林依从性的影响。干预组子痫前期知识评分平均提高4.0分(95%CI:2.4,5.6),对照组提高2.0分(95%CI:0.3,3.9),组间平均差异为1.8分(95%CI:-0.5,4.2),未达统计学显著;纳入胎死病例末次评分后,干预组提高4.8分(95%CI:3.3,6.9),对照组提高1.9分(95%CI:0.3,3.6),干预组多提高2.5分(95%CI:0.3,4.8)。基于电子药房数据,干预组阿司匹林依从性为81%,对照组为65%,差异为15%(95%CI:-9,37%),呈升高趋势但未达统计学显著。
要点
- 干预组子痫前期知识评分平均提高4.0分,对照组提高2.0分,组间差异1.8分(95%CI:-0.5,4.2),未达统计学显著。
- 纳入胎死病例末次评分后,干预组多提高2.5分(95%CI:0.3,4.8),差异达统计学显著。
- 电子药房数据显示阿司匹林依从性干预组81% vs 对照组65%,差异15%(95%CI:-9,37%),呈升高趋势但未达统计学显著。
核心结论
- 接受教育工具的SLE孕妇子痫前期知识改善程度大于对照组。
- 该工具可能改善SLE妊娠中的阿司匹林使用并有助于优化结局。
研究设计与样本
- 两臂平行随机对照试验,招募妊娠≤17周的SLE孕妇,随机分为单纯常规护理组或常规护理联合教育工具组。
- 教育工具为含SLE子痫前期及阿司匹林预防信息图表的塑封卡片。
- 共纳入73例,其中38例随机分配至干预组。
- 主要结局为妊娠中期访视时子痫前期知识评分的差异。
主要发现
- 在持续妊娠的主要分析中,干预组子痫前期知识评分平均提高4.0分(95%CI:2.4,5.6),对照组提高2.0分(95%CI:0.3,3.9),干预组平均多提高1.8分(95%CI:-0.5,4.2),未达统计学显著。
- 纳入胎死病例(每组各6例)末次妊娠评分后,干预组提高4.8分(95%CI:3.3,6.9),对照组提高1.9分(95%CI:0.3,3.6),干预组平均多提高2.5分(95%CI:0.3,4.8),差异达统计学显著。
- 基于电子药房数据,干预组阿司匹林依从性为81%,对照组为65%,差异为15%(95%CI:-9,37%),呈升高趋势但未达统计学显著。
临床怎么用
- 作者认为该教育工具可能改善SLE妊娠中的阿司匹林使用并有助于优化结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the effect of an educational tool on preeclampsia knowledge, as well as aspirin (ASA) use and adherence in pregnant SLE women. METHODS: A two-arm parallel randomized controlled trial was conducted recruiting pregnant SLE women up to 17 weeks' gestation. Participants were randomly assigned to receive either usual-care alone or usual-care plus the tool (laminated card incorporating infographics on preeclampsia in SLE and ASA for prevention). The primary outcome was difference in preeclampsia knowledge scores at the second-trimester visit. RESULTS: Of 73 women included, 38 were randomized to the intervention. In the primary analysis of ongoing pregnancies, increase in the mean preeclampsia knowledge scores was 4.0 points (95% CI: 2.4, 5.6) in the intervention group and 2.0 points (95% CI: 0.3, 3.9) in controls, with a mean difference of 1.8 points higher (95% CI: -0.5, 4.2) favouring the intervention. Including end-of-pregnancy scores of women with fetal loss (six in each group), the difference was 4.8 points (95% CI: 3.3, 6.9) in the intervention group and 1.9 points (95% CI: 0.3, 3.6) in controls, with a mean increase of 2.5 points (95% CI: 0.3, 4.8) more for the intervention. Using electronic pharmacy data, there was a trend for higher ASA adherence in the intervention group (81%) vs controls (65%; difference 15%, 95% CI: -9, 37%). CONCLUSION: Women with SLE who received an educational tool had greater improvement in preeclampsia knowledge vs controls. This tool may improve ASA use in SLE pregnancies and help optimize outcomes. TRIAL REGISTRATION: ClinicalTrials.gov, http://clinicaltrials.gov, NCT03749044.
引用
- Lee JE, Mendel A, Malhamé I, et al. An educational tool to improve PREeclamPsia knowledge and Aspirin adheRence in lupus prEgnancies: the PREPARE trial. Rheumatology (Oxford). 2025. PMID: 40578323. doi:10.1093/rheumatology/keaf334
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。